Clinical research and testing provider Novotech Health Holdings Pte., which is backed by PE firm TPG, has announced the completion of a financing round of $760 million (about A$1.06 billion) from a group of global investors.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
